News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

GLP-1 agonists induce weight loss in diabetic patients with obesity
17 Feb 2023
Initiation of a glucagon-like peptide-1 (GLP-1) agonist at standard glycaemic control doses may result in modest weight loss through 72 weeks in patients with overweight or obesity and type 2 diabetes, suggest the results of a real-world study.
17 Feb 2023

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
17 Feb 2023
In women with postpartum hypertension, treatment with combined hydrochlorothiazide (HCTZ)/lisinopril yields greater blood pressure (BP)-lowering benefit than nifedipine monotherapy, according to the results of a pilot study.
17 Feb 2023

FTD/TPI-bevacizumab combo a new SoC for metastatic CRC?
16 Feb 2023
byAudrey Abella
A combination of trifluridine/tipiracil (FTD/TPI) and bevacizumab provided significant survival benefit when used as third-line treatment for refractory metastatic colorectal cancer (CRC) than FTD/TPI alone, findings from the phase III SUNLIGHT study suggest.
16 Feb 2023






